Software Application Profiles: useful and novel software for epidemiological data analysis

The Analysis of Qualitative Study Data Using Software

The use of softwares for analyzing research data is increasing everyday. Making use of softwares specified for the analysis of qualitative data has begun since 20 years ago, and has been exposed to so many changes so far. Researchers have used the existing softwares such as word processors to facilitate the analysis practice, even before using specific softwares. Different softwares have severa...

A Novel ICA-based Estimator for Software Cost Estimation

One of the most important and valuable goal of software development life cycle is software cost estimation or SCE. During the recent years, SCE has attracted the attention of researchers due to huge amount of software project requests. There have been proposed so many models using heuristic and meta-heuristic algorithms to do machine learning process for SCE. COCOMO81 is one of the most popular...

Software Application Profile: Opal and Mica: open-source software solutions for epidemiological data management, harmonization and dissemination

Motivation Improving the dissemination of information on existing epidemiological studies and facilitating the interoperability of study databases are essential to maximizing the use of resources and accelerating improvements in health. To address this, Maelstrom Research proposes Opal and Mica, two inter-operable open-source software packages providing out-of-the-box solutions for epidemiologi...

ELISA Analyzer •, a Software to Analyze and Optimize ELISA Data

ELISA data is usually handled in the MS Excel worksheets through different methods and different formulas. Accurate and precise calculations of the data is time consuming and tedious. ELISA Analyzer was developed with a user friendly interface to streamline titration and analysis of the data obtained from ELISA and improve rapid and lucid presentation of the results. The software can also hel...

Is Medical Application Software a New Strategy for Oncologists?